| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |